ALB and type 2 diabetes mellitus: Adding esaxerenone to the existing renin-angiotensin system inhibitor therapy in patients with type 2 diabetes and microalbuminuria has shown to increase the likelihood of the normalization of the albumin levels and reduced progression of albuminuria [23].